Byron Robinson

Insider Reports History

Location
La Jolla, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Byron Robinson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Strategy Officer Common Stock 28,000 $1,606,220 $57.36 02 Jan 2025 Direct
Janux Therapeutics, Inc. Chief Strategy Officer Stock option (right to buy) 98,000 02 Jan 2025 Direct

Insider Reports Filed by Byron Robinson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Strategy Officer 03 Jan 2025, 20:10
JANX Janux Therapeutics, Inc. 02 Jan 2024 1 $0 4 Chief Strategy Officer 03 Jan 2024, 16:53
JANX Janux Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Strategy Officer 05 Jan 2023, 15:35
JANX Janux Therapeutics, Inc. 01 Mar 2022 1 $0 4 Chief Strategy Officer 03 Mar 2022, 16:06
JANX Janux Therapeutics, Inc. 01 Mar 2022 0 $0 3 Chief Strategy Officer 03 Mar 2022, 16:03